Cargando…

Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours

The aim of this study was to define prognostic parameters for survival in patients with malignant germ cell tumours progressing after platinum-based induction chemotherapy with or without surgery. A total of 164 progressing patients (testicular: 83%, extragonadal: 17%) were identified out of 795 pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fosså, S D, Stenning, S P, Gerl, A, Horwich, A, Clark, P I, Wilkinson, P M, Jones, W G, Williams, M V, Oliver, R T, Newlands, E S, Mead, G M, Cullen, M H, Kaye, S B, Rustin, G J S, Cook, P A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363071/ https://www.ncbi.nlm.nih.gov/pubmed/10424741 http://dx.doi.org/10.1038/sj.bjc.6690534

Ejemplares similares

Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17)
por: Dearnaley, D P, et al.
Publicado: (2005)

Long-term follow-up of residual masses after chemotherapy in patients with non-seminomatous germ cell tumours
por: Napier, M P, et al.
Publicado: (2000)

A Medical Research Council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma
por: Horwich, A, et al.
Publicado: (2000)

Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT)
por: Bono, J S de, et al.
Publicado: (2000)

Frequency of serum tumour marker monitoring in patients with non-seminomatous germ cell tumours.
por: Seckl, M. J., et al.
Publicado: (1990)

Advances in the management of metastatic non-seminomatous germ cell tumours during the cisplatin era: a single-institution experience.
por: Gerl, A., et al.
Publicado: (1996)

A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial
por: Mead, G M, et al.
Publicado: (2005)

Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour
por: Johnson, P J, et al.
Publicado: (1999)

Sequential resection of residual abdominal and thoracic masses after chemotherapy for metastatic non-seminomatous germ cell tumours.
por: Gerl, A., et al.
Publicado: (1994)

The changing role of surgery in metastatic non-seminomatous germ cell tumour.
por: Cassidy, J., et al.
Publicado: (1992)

The role of radiotherapy after chemotherapy in the management of persistent para-aortic nodal disease in non-seminomatous germ cell tumours.
por: Read, G., et al.
Publicado: (1986)

Management preferences in stage I non-seminomatous germ cell tumours of the testis: an investigation among patients, controls and oncologists.
por: Cullen, M. H., et al.
Publicado: (1996)

Surgery in metastatic non-seminomatous germ cell tumours.
por: Tobias, J. S.
Publicado: (1992)

The epidemiology of non-seminomatous germ cell tumours in the west of Scotland 1975-89.
por: Harding, M., et al.
Publicado: (1995)

Human germ cell tumours: expression of γ-glutamyl transpeptidase and sensitivity to cisplatin
por: Hanigan, M H, et al.
Publicado: (1999)

Bone disease in testicular and extragonadal germ cell tumours.
por: Hitchins, R. N., et al.
Publicado: (1988)

A Scottish national audit of current patterns of management for patients with testicular non-seminomatous germ-cell tumours. The Scottish Radiological Society and the Scottish Committee of the Royal College of Radiologists.
por: Howard, G. C., et al.
Publicado: (1995)

Results of treatment of non seminomatous germ cell tumours; 122 consecutive cases in the West of Scotland, 1981-1985.
por: Graham, J., et al.
Publicado: (1988)

Distinct Proteomic Profile of Spermatozoa from Men with Seminomatous and Non-Seminomatous Testicular Germ Cell Tumors
por: Panner Selvam, Manesh Kumar, et al.
Publicado: (2020)

Prognostic factors in clinical stage I non-seminomatous germ-cell tumours of the testis.
por: Raghavan, D., et al.
Publicado: (1982)

The utility of tumour markers in assessing the response to chemotherapy in advanced bladder cancer
por: Cook, A M, et al.
Publicado: (2000)

The effect of intensity of administered treatment on the outcome of germ cell tumours treated with POMB/ACE chemotherapy.
por: Crawford, S. M., et al.
Publicado: (1989)

Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours
por: Fizazi, K, et al.
Publicado: (2002)

Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosis
por: Schlippe, M von, et al.
Publicado: (2001)

Germ cell tumour chemotherapy.
por: Horwich, A.
Publicado: (1989)

Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse
por: Hain, S F, et al.
Publicado: (2000)

Surveillance or etoposide-containing combination chemotherapy for stage I non-seminomatous germ cell tumours of the testis (NSGCTT)
por: Colls, B. M.
Publicado: (1994)

Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma.
por: Tait, D., et al.
Publicado: (1984)

A Scottish national mortality study assessing cause of death, quality of and variation in management of patients with testicular non-seminomatous germ-cell tumours. The Scottish Radiological Society and the Scottish Standing Committee of the Royal College of Radiologists.
por: Howard, G. C., et al.
Publicado: (1995)

High-dose therapy including carboplatin adjusted for renal function in patients with relapsed or refractory germ cell tumour: outcome and prognostic factors.
por: Lyttelton, M. P., et al.
Publicado: (1998)

Salvage therapy of germ cell tumours.
por: Horwich, A.
Publicado: (1995)

The management of low-stage non-seminomatous germ cell tumors
por: Lim, Louise, et al.
Publicado: (2012)

Risk factors for testicular germ cell tumours by histological tumour type
por: Coupland, C A C, et al.
Publicado: (1999)

Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours
por: McNeish, I A, et al.
Publicado: (2004)

Non-Seminomatous Germ Cell Tumor Presenting with Superior Vena Cava Syndrome
por: Soriano, Paolo K., et al.
Publicado: (2017)

Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin
por: Mitry, E, et al.
Publicado: (1999)

Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials
por: Bokemeyer, C, et al.
Publicado: (2004)

Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948)
por: Fosså, S D, et al.
Publicado: (2005)

5-Azacitidine Exerts Prolonged Pro-Apoptotic Effects and Overcomes Cisplatin-Resistance in Non-Seminomatous Germ Cell Tumor Cells
por: Oing, Christoph, et al.
Publicado: (2018)

Two Cases of Cerebral Sinus Venous Thrombosis Following Chemotherapy for Non-Seminomatous Germ Cell Tumor
por: Papet, C., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ogusft1kkcdr4asl9g5lhnmdpm